Prolight Diagnostics
Logotype for Prolight Diagnostics

Prolight Diagnostics (PRLD) investor relations material

Prolight Diagnostics Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Prolight Diagnostics
Q4 2025 earnings summary26 Feb, 2026

Executive summary

  • Achieved key milestones in commercializing the Psyros platform, including assay design freeze and positive patient data demonstrating laboratory-grade performance in whole blood.

  • Presented a fully functional commercial prototype at an international congress, receiving strong interest from potential partners and end users.

  • Strengthened IP position with new patents granted in Europe and Japan.

  • Secured SEK 100 million in funding through a fully subscribed rights issue, supporting completion of Psyros and pilot manufacturing preparations.

  • Entering 2026 focused on final system verification, manufacturing validation, and clinical performance study ahead of a planned 2027 commercial launch.

Financial highlights

  • Net sales remained at 0 SEK for both Q4 and the full year 2025, unchanged from the previous year.

  • Other operating income was 10,670 TSEK in Q4 (down from 15,317 TSEK) and 26,854 TSEK for the year (up from 19,133 TSEK).

  • Operating profit (EBIT) was -13,060 TSEK in Q4 (down from 1,492 TSEK) and -53,249 TSEK for the year (down from -27,270 TSEK).

  • Profit after tax was -12,123 TSEK in Q4 (down from 2,014 TSEK) and -49,708 TSEK for the year (down from -26,937 TSEK).

  • Earnings per share before and after dilution: -1.01 SEK in Q4 (vs. -0.29 SEK) and -4.13 SEK for the year (vs. -0.04 SEK).

  • Cash flow from operating activities was -11,546 TSEK in Q4 (vs. 6,448 TSEK) and -37,005 TSEK for the year (vs. -27,946 TSEK).

  • Cash and cash equivalents at year-end were 40,606 TSEK (up from 15,734 TSEK).

Outlook and guidance

  • Focus for 2026 is on final system verification, manufacturing process validation, pilot production, and initiation of a European multicentre clinical performance study.

  • Commercial launch targeted for 2027, with scalable cartridge production capacity established.

What are the key 2026 milestones for Psyros?
Explain the Psyros additional purchase price adjustment
What clinical areas beyond troponin are targeted?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Prolight Diagnostics earnings date

Logotype for Prolight Diagnostics
Q1 202626 May, 2026
Prolight Diagnostics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Prolight Diagnostics earnings date

Logotype for Prolight Diagnostics
Q1 202626 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Prolight Diagnostics AB is a Sweden-based medical technology company specializing in the development of point-of-care diagnostic systems. The company focuses on creating innovative platforms for rapid and accurate biomarker testing to support timely decision-making in healthcare settings. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage